Discontinuation report MYLAN-RISEDRONATE

Last updated on 2017-11-02 History
Report ID 16151
Drug Identification Number 02357984
Brand name MYLAN-RISEDRONATE
Common or Proper name RISEDRONATE
Company Name MYLAN PHARMACEUTICALS ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) RISEDRONATE SODIUM
Strength(s) 35MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30BT, 4BL
ATC code M05BA
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for discontinuation Business reasons
Anticipated discontinuation date 2017-11-01
Actual discontinuation date 2017-11-01
Remaining supply date 2017-11-01
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments Last Lot expires 31-Jan-2018
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2017-11-02 French Compare
v5 2017-11-02 English Compare
v4 2017-10-23 French Compare
v3 2017-10-23 English Compare
v2 2017-07-18 French Compare
v1 2017-07-18 English Compare

Showing 1 to 6 of 6